Follow
Hassan Alhazmi
Hassan Alhazmi
Verified email at jazanu.edu.sa
Title
Cited by
Cited by
Year
Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents
A Najmi, SA Javed, M Al Bratty, HA Alhazmi
Molecules 27 (2), 349, 2022
1822022
FT-IR spectroscopy for the identification of binding sites and measurements of the binding interactions of important metal ions with bovine serum albumin
HA Alhazmi
Scientia Pharmaceutica 87 (1), 5, 2019
1302019
Thermophoresis for characterizing biomolecular interaction
M Asmari, R Ratih, HA Alhazmi, S El Deeb
Methods 146, 107-119, 2018
1152018
Medicinal plants and isolated molecules demonstrating immunomodulation activity as potential alternative therapies for viral diseases including COVID-19
HA Alhazmi, A Najmi, SA Javed, S Sultana, W Ahsan
Frontiers in immunology 12, 637553, 2021
872021
Targeting peroxisome proliferator-activated receptors using thiazolidinediones: Strategy for design of novel antidiabetic drugs
N Thangavel, M Al Bratty, SA Javed, W Ahsan, HA Alhazmi
International journal of medicinal chemistry 2017, 2017
852017
Development and validation of LC–MS/MS method for simultaneous determination of metformin and four gliptins in human plasma
M Al Bratty, HA Alhazmi, SA Javed, KG Lalitha, M Asmari, J Wölker, ...
Chromatographia 80, 891-899, 2017
692017
Phytochemical, cytotoxic, and antimicrobial evaluation of the fruits of miswak plant, Salvadora persica L.
M Al Bratty, HA Makeen, HA Alhazmi, SM Syame, AN Abdalla, ...
Journal of Chemistry 2020, 1-11, 2020
682020
Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review
M Albratty, HA Alhazmi
Arabian Journal of Chemistry 15 (6), 103846, 2022
672022
Treatment of SARS-CoV-2: How far have we reached?
W Ahsan, S Javed, M Al Bratty, HA Alhazmi, A Najmi
Drug discoveries & therapeutics 14 (2), 67-72, 2020
632020
Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials
B Mangla, S Javed, MH Sultan, P Kumar, K Kohli, A Najmi, HA Alhazmi, ...
Phytotherapy Research 35 (10), 5440-5458, 2021
562021
Cough suppressant herbal drugs: A review
S Sultana, A Khan, MM Safhi, HA Alhazmi
Int. J. Pharm. Sci. Invent 5 (5), 15-28, 2016
532016
Recent advances in affinity capillary electrophoresis for binding studies
HM Albishri, SE Deeb, N AlGarabli, R AlAstal, HA Alhazmi, M Nachbar, ...
Bioanalysis 6 (24), 3369-3392, 2014
512014
Bioactive natural antivirals: An updated review of the available plants and isolated molecules
S Mohan, MM Elhassan Taha, HA Makeen, HA Alhazmi, M Al Bratty, ...
Molecules 25 (21), 4878, 2020
492020
Data quality in drug discovery: the role of analytical performance in ligand binding assays
H Wätzig, I Oltmann-Norden, F Steinicke, HA Alhazmi, M Nachbar, ...
Journal of computer-aided molecular design 29, 847-865, 2015
492015
A comprehensive platform to investigate protein–metal ion interactions by affinity capillary electrophoresis
HA Alhazmi, M Nachbar, HM Albishri, D Abd El-Hady, S Redweik, ...
Journal of Pharmaceutical and Biomedical Analysis 107, 311-317, 2015
472015
A comprehensive platform to investigate protein–metal ion interactions by affinity capillary electrophoresis
HA Alhazmi, M Nachbar, HM Albishri, D Abd El-Hady, S Redweik, ...
Journal of Pharmaceutical and Biomedical Analysis 107, 311-317, 2015
472015
Metabolic stability assessment of new parp inhibitor talazoparib using validated lc–ms/ms methodology: In silico metabolic vulnerability and toxicity studies
MW Attwa, AA Kadi, AS Abdelhameed, HA Alhazmi
Drug design, development and therapy, 783-793, 2020
432020
Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MS
MW Attwa, HW Darwish, HA Alhazmi, AA Kadi
Clinica Chimica Acta 485, 298-304, 2018
392018
Graphene-based biosensors for disease theranostics: Development, applications, and recent advancements
HA Alhazmi, W Ahsan, B Mangla, S Javed, MZ Hassan, M Asmari, ...
Nanotechnology Reviews 11 (1), 96-116, 2021
362021
Synthesis and evaluation of some new 1, 3, 4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents
M Albratty, KA El-Sharkawy, HA Alhazmi
Acta pharmaceutica 69 (2), 261-276, 2019
352019
The system can't perform the operation now. Try again later.
Articles 1–20